Predictors of discontinuation of Biologic DMARD therapy due to remission in patients with Rheumatoid Arthritis in a National Registry (BIOBADASER)
11/01/2017
Jose A. Gómez-Puerta, M Victoria Hernandez, Fernando Alonso, Kazuki Yoshida, Raimon Sanmartí, Dan H. Solomon, Juan J. Gómez-Reino
Jose A. Gómez-Puerta, M Victoria Hernandez, Fernando Alonso, Kazuki Yoshida, Raimon Sanmartí, Dan H. Solomon, Juan J. Gómez-Reino on behalf of BIOBADASER 2.0 study group. Predictors of discontinuation of Biologic DMARD therapy due to remission in patients with Rheumatoid Arthritis in a National Registry (BIOBADASER). Congreso ACR 2014. Póster.